Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial.
about
Pharmacologic interventions for the prevention and treatment of retinopathy of prematurityIntravitreal injection of bevacizumab for retinopathy of prematurity.Emerging roles for antiangiogenesis factors in management of ocular disease.Motivational interviewing or reminders for glaucoma medication adherence: Results of a multi-site randomised controlled trial.Anti-angiogenic effect of KH902 on retinal neovascularization.
P2860
Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@ast
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@en
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@nl
type
label
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@ast
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@en
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@nl
prefLabel
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@ast
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@en
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@nl
P356
P1476
Intravitreal pegaptanib as adj ...... ed multicenter clinical trial.
@en
P2093
Helen A Mintz-Hittner
P304
P356
10.5301/EJO.5000176
P577
2012-09-01T00:00:00Z